Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    TLRY ROE (Return on Equity)

    As of 2025-07-13, the ROE (Return on Equity) of Tilray Brands Inc (TLRY) is -7.1%.

    ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.

    TLRY ROE (Return on Equity) - Historical Value
    DateValue
    2024-05-31 -7.1%
    2023-05-31 -43.8%
    2022-05-31 -10.8%
    2021-05-31 -8.2%
    2020-12-31 -72.5%
    2019-12-31 -112.6%
    2018-12-31 -34.2%
    2017-12-31 159.2%
    2016-12-31 -316%
    -
    TLRY ROE (Return on Equity) - Peers Comparison
    TickerNameValue
    ACB.TOAurora Cannabis Inc0.4%
    ACRG.A.U.CNAcreage Holdings Inc-227.9%
    AMPHAmphastar Pharmaceuticals Inc21.8%
    ANIPANI Pharmaceuticals Inc-4.3%
    APHA.TOAphria Inc-4.7%
    AVDLAvadel Pharmaceuticals PLC-66.1%
    AYR.A.CNAyr Wellness Inc-46.8%
    CORTCorcept Therapeutics Inc20.8%
    CRON.TOCronos Group Inc3.9%
    CWEB.TOCharlotte's Web Holdings Inc-110.5%
    CXRXFAdvanz Pharma Corp Ltd-986.8%
    GUD.TOKnight Therapeutics Inc0.5%
    HARV.CNHarvest Health & Recreation Inc-16%
    HEXO.TOHexo Corp-340.3%
    HRMYHarmony Biosciences Holdings Inc22%
    INVAInnoviva Inc3.4%
    MRNSMarinus Pharmaceuticals Inc-843.5%
    NGMNGM Biopharmaceuticals Inc-95.8%
    OGI.TOOrganiGram Holdings Inc-14.9%
    PCRXPacira Biosciences Inc-12.8%
    SIGASIGA Technologies Inc27.4%
    SNDLSNDL Inc-8.4%
    SUPNSupernus Pharmaceuticals Inc7.1%
    TAROTaro Pharmaceutical Industries Ltd3%
    TBPHTheravance Biopharma Inc-32.1%
    TRUL.CNTrulieve Cannabis Corp-12.7%
    TXMDTherapeuticsMD Inc-8%
    ZGNXZogenix Inc14.3%
    Tickers added to watchlist